Secondary market offering

Lemonade Announces Upsizing and Pricing of Public Offering of Common Stock

Thursday, January 14, 2021 - 1:41am

Lemonade, Inc. (Lemonade) (NYSE: LMND), the insurance company powered by artificial intelligence and behavioral economics, today announced the pricing of the underwritten public offering of 3,300,000 shares of its common stock by Lemonade (the Primary Offering) and 1,524,314 shares of its common stock by certain selling stockholders (the Secondary Offering and together with the Primary Offering, the Offering), at a price to the public of $165.00 per share.

Key Points: 
  • Lemonade, Inc. (Lemonade) (NYSE: LMND), the insurance company powered by artificial intelligence and behavioral economics, today announced the pricing of the underwritten public offering of 3,300,000 shares of its common stock by Lemonade (the Primary Offering) and 1,524,314 shares of its common stock by certain selling stockholders (the Secondary Offering and together with the Primary Offering, the Offering), at a price to the public of $165.00 per share.
  • The Offering was upsized from the previously announced offering size of 4,524,314 shares.
  • The underwriters will also have 30-day options to purchase up to an additional 723,647 shares of Lemonades common stock from Lemonade.
  • Lemonade is currently available for most of the United States, Germany, the Netherlands and France and continues to expand globally.

Lemonade Announces Proposed Public Offering of Common Stock

Monday, January 11, 2021 - 9:54pm

Lemonade, Inc. (Lemonade) (NYSE:LMND), the insurance company powered by artificial intelligence and behavioral economics, today announced that it intends to offer 3,000,000 shares of its common stock for sale in an underwritten public offering (the Primary Offering).

Key Points: 
  • Lemonade, Inc. (Lemonade) (NYSE:LMND), the insurance company powered by artificial intelligence and behavioral economics, today announced that it intends to offer 3,000,000 shares of its common stock for sale in an underwritten public offering (the Primary Offering).
  • Certain selling stockholders of Lemonade also intend to offer 1,524,314 shares of Lemonades common stock for sale in the offering (the Secondary Offering and together with the Primary Offering, the Offering).
  • Lemonade also intends to grant the underwriters 30-day options to purchase up to an additional 678,647 shares of Lemonades common stock.
  • Lemonade will not receive any proceeds from the sale of shares by the selling stockholders in the Secondary Offering.

Sequans Communications S.A. Announces Closing of Over-Allotment Option Related to Underwritten Public Secondary Offering of American Depositary Shares

Monday, December 14, 2020 - 3:10pm

Each ADS represents four ordinary shares of the Company, nominal value 0.02 per share The Option exercise closed on December 14, 2020.

Key Points: 
  • Each ADS represents four ordinary shares of the Company, nominal value 0.02 per share The Option exercise closed on December 14, 2020.
  • After the completion of the underwritten public secondary offering, including the over-allotment option, Sequans current total ADSs outstanding are 33,239,788.
  • We were pleased to facilitate this secondary offering, said Georges Karam, CEO of Sequans.
  • Pursuant to an underwriting agreement dated December 7, 2020, B. Riley Securities, Inc. acted as the underwriter of the secondary offering.

NAPCO Security Technologies Announces Secondary Public Offering of 2,233,071 Shares of Common Stock

Thursday, December 10, 2020 - 9:01pm

Additionally, the Selling Stockholder intends to grant the underwriters a 30-day option to purchase from him up to an additional 334,961 shares of common stock.

Key Points: 
  • Additionally, the Selling Stockholder intends to grant the underwriters a 30-day option to purchase from him up to an additional 334,961 shares of common stock.
  • NAPCO is not issuing or selling any shares of common stock in the offering and therefore will not receive any of the proceeds from the sale of the outstanding shares of common stock beneficially owned by the Selling Stockholder.
  • Upon completion of the proposed secondary offering, and assuming full exercise by the underwriters of the option to purchase additional shares from the Selling Stockholder, the Selling Stockholder will continue to own approximately 20% of the issued and outstanding shares of common stock of NAPCO.
  • These forward-looking statements include, but are not limited to, statements relating to the proposed secondary public offering, the exercise of the option to purchase additional shares and the purpose of the proposed secondary public offering.

Array Technologies, Inc. Announces Closing of Secondary Offering of 36,656,250 Shares

Monday, December 7, 2020 - 9:10pm

The Company did not receive any of the proceeds from the sale of shares by the Selling Stockholder.

Key Points: 
  • The Company did not receive any of the proceeds from the sale of shares by the Selling Stockholder.
  • Goldman Sachs & Co. LLC and J.P. Morgan acted as joint book-running managers and representatives of the underwriters for the offering.
  • A registration statement relating to the offering has been filed with the SEC and declared effective on December 2, 2020.
  • This press release contains forward looking statements, including statements regarding the secondary offering.

Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares

Friday, December 4, 2020 - 11:34am

GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced the pricing of an upsized secondary public offering by certain selling shareholders (the Offering) of 2,243,000 American Depositary Shares (ADSs), each representing one Class A ordinary share of the Company, at a public offering price of US$25.75 per ADS.

Key Points: 
  • GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the Company or Burning Rock), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced the pricing of an upsized secondary public offering by certain selling shareholders (the Offering) of 2,243,000 American Depositary Shares (ADSs), each representing one Class A ordinary share of the Company, at a public offering price of US$25.75 per ADS.
  • The aggregate offering size of the Offering is approximately US$57.8 million, assuming the underwriters do not exercise their option to purchase additional ADSs.
  • Morgan Stanley & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC are acting as joint bookrunners for the Offering.
  • The Offering is being made only by means of a prospectus forming part of the effective registration statement.

Shift4 Payments Announces Pricing of Secondary Offering of Class A Common Stock

Thursday, December 3, 2020 - 11:30am

Shift4 Payments, Inc. (Shift4) (NYSE: FOUR), a leading independent provider of integrated payment processing and technology solutions, today announced the pricing of the underwritten public offering of 8,000,000 shares of Shift4s Class A common stock by certain selling stockholders (the Secondary Offering), at a price to the public of $55.50 per share.

Key Points: 
  • Shift4 Payments, Inc. (Shift4) (NYSE: FOUR), a leading independent provider of integrated payment processing and technology solutions, today announced the pricing of the underwritten public offering of 8,000,000 shares of Shift4s Class A common stock by certain selling stockholders (the Secondary Offering), at a price to the public of $55.50 per share.
  • The underwriters will also have a 30-day option to purchase up to an additional 1,200,000 shares of Shift4s Class A common stock from the selling stockholders.
  • Shift4 is not selling any shares of Class A common stock in the Secondary Offering, will not receive any proceeds from the sale of shares by the selling stockholders and will not bear any offering expenses.
  • The offering of Notes is not contingent upon the Secondary Offering, and the Secondary Offering is not contingent upon the offering of Notes.

Evoqua Water Technologies Announces Pricing of Secondary Public Offering

Wednesday, December 2, 2020 - 11:45am

Evoqua Water Technologies Corp. (NYSE: AQUA) announced the pricing of a secondary public offering of 12 million shares of its common stock by certain institutional shareholders of the company, including certain affiliates of AEA Investors LP (collectively, the Selling Shareholders), which is expected to result in gross proceeds of approximately $301.8 million.

Key Points: 
  • Evoqua Water Technologies Corp. (NYSE: AQUA) announced the pricing of a secondary public offering of 12 million shares of its common stock by certain institutional shareholders of the company, including certain affiliates of AEA Investors LP (collectively, the Selling Shareholders), which is expected to result in gross proceeds of approximately $301.8 million.
  • The offering is expected to close on December 4, 2020, subject to the satisfaction of customary closing conditions.
  • The company is not selling any shares in the offering and will not receive any proceeds from the sale of shares being sold by the Selling Shareholders in the offering.
  • Evoqua Water Technologies is a leading provider of mission critical water and wastewater treatment solutions, offering a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers who value water.

Evoqua Water Technologies Announces Launch of Secondary Public Offering

Tuesday, December 1, 2020 - 9:27pm

Evoqua Water Technologies Corp. (NYSE: AQUA) today announced the launch of a secondary public offering of 12 million shares of its common stock by certain institutional shareholders of the company, including certain affiliates of AEA Investors LP (collectively, the Selling Shareholders).

Key Points: 
  • Evoqua Water Technologies Corp. (NYSE: AQUA) today announced the launch of a secondary public offering of 12 million shares of its common stock by certain institutional shareholders of the company, including certain affiliates of AEA Investors LP (collectively, the Selling Shareholders).
  • The company is not selling any shares in the offering and will not receive any proceeds from the sale of shares being sold by the Selling Shareholders in the offering.
  • The offering of these securities is being made only by means of a prospectus supplement and an accompanying prospectus.
  • Evoqua Water Technologies is a leading provider of mission critical water and wastewater treatment solutions, offering a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers who value water.